Sanofi touts new drugs but diabetes outlook disappoints

November 20, 2014 4:04 PM

3 0

Sanofi touts new drugs but diabetes outlook disappoints

PARIS (Reuters) - Sanofi, which sacked its chief executive three weeks ago, gave a weak sales outlook for its diabetes drugs on Thursday, overshadowing plans to reap more than 30 billion euros ($38 billion) from new medicines.

The French drugmaker said it aimed to launch up to 18 new drugs by the end of 2020 and told investors it was working hard to find the best possible successor to ex-CEO Chris Viehbacher.

Read more

To category page

Loading...